000411.SZ
Zhejiang Int'l Group Co., Ltd.
SZSE · Healthcare · F 批发零售 · CN
CNY 9.58
−0.93%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 33.8B | 33.7B | 33.4B | 32.1B | 30.6B |
| Cost of Revenue | 31.4B | 31.3B | 31.1B | 29.9B | 28.6B |
| Gross Profit | 2.4B | 2.4B | 2.3B | 2.2B | 2.0B |
| Operating Expenses | |||||
| R&D Expense | 19.6M | 20.3M | 12.0M | 8.8M | 12.9M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 396.3M | 363.3M | 417.5M | 436.5M | 445.4M |
| Selling & Marketing Expense | 981.5M | 928.9M | 887.5M | 821.4M | 685.1M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.6B | 1.5B | 1.5B | 1.5B | 1.4B |
| Cost and Expenses | 33.1B | 32.9B | 32.6B | 31.3B | 30.0B |
| Operating Income (EBIT) | 822.2M | 857.5M | 838.6M | 826.0M | 644.1M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 783.8M | 816.7M | 802.8M | 801.4M | 626.2M |
| Income Tax Expense | 195.7M | 212.7M | 190.9M | 212.7M | 163.3M |
| Bottom Line | |||||
| Net Income | 480.6M | 501.2M | 525.5M | 488.7M | 212.4M |
| Earnings from Cont. Ops | 588.0M | 604.0M | 611.9M | 588.7M | 463.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 480.6M | 501.2M | 525.5M | 488.7M | 212.4M |
| Per Share | |||||
| Basic EPS | CN¥0.91 | CN¥0.96 | CN¥1.02 | CN¥1.09 | CN¥0.71 |
| Diluted EPS | CN¥0.91 | CN¥0.94 | CN¥0.96 | CN¥1.03 | CN¥0.65 |
| Revenue Per Share | CN¥60.79 | CN¥64.50 | CN¥64.73 | CN¥71.48 | CN¥102.35 |
| Shares | |||||
| Basic Shares Outstanding | 556.6M | 522.1M | 515.2M | 448.4M | 299.2M |
| Diluted Shares Outstanding | 556.6M | 522.1M | 515.2M | 448.4M | 299.2M |
| Profitability Metrics | |||||
| EBITDA | — | 962.1M | 938.6M | 920.5M | 742.6M |
| D&A | — | 104.6M | 100.0M | 94.5M | 98.5M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026